Chemotherapy Does Not Increase Risk Of Cancer In Offspring Of Patients Treated as Children

May 13, 1997

BUFFALO, N.Y. -- Chemotherapy given to young cancer patients does not appear to increase the risk of cancer in their offspring, the first large study of children of survivors of pediatric cancer has shown.

Results of the study, conducted by researchers at the University at Buffalo and Roswell Park Cancer Institute, appear in the most recent issue of Archives of Pediatrics & Adolescent Medicine.

"This study is important because we don't know whether therapy we give these patients will affect their children," said Daniel M. Green, M.D., professor of pediatrics at UB and Roswell Park and the study's primary author.

Green said that, to his knowledge, this study involved the largest number of fertile survivors of childhood cancer who had received chemotherapy to date. "There is essentially no data so far," he said. "This is one of the few studies to look at pregnancy outcomes. These agents are mutagenic and it was possible they could produce injury to chromosomes in germ cells that would result in congenital anomalies or cancer in their offspring. This doesn't appear to be the case."

The study involved a cohort of 405 successively treated patients who were diagnosed with cancer at Roswell Park between Jan. 1, 1960 and Dec. 31, 1989, and were 18 years of age or older at the most recent follow-up visit.

Within this group, 148 patients reported that they, their spouse or female companion had become pregnant at least once since completing cancer treatment. Ninety-one of these patients had received chemotherapy and had produced a total of 153 children.

Analysis of the health records of the children of the chemotherapy patients showed that none of the offspring had developed cancer. The frequency of birth defects, or congenital anomalies, was slightly less than for the general population -- 3.3 percent versus 3.5 percent.

There was no difference in frequency of birth defects among children of female patients and children born to spouses or female companions of male patients. Nor was there any relationship between anomalies and the patient's age at cancer diagnosis or the amount of time elapsed since completion of treatment.

Green said that while the results of the study are promising, the number of offspring is still small and most of them are still younger than their parents were when they were diagnosed with cancer. He said the sample also is too small to determine if the parents may have transmitted a mutation in a cancer-predisposition gene that caused their own cancer, or if they may have transmitted a new mutation in a cancer-predisposition gene induced by their own treatment.

The researchers will continue to follow this population of patients and offspring to search for more definitive answers.

Also participating in the research were Albert Fiorello, M.D., and Michael A. Zevon, Ph.D., of UB, and Brenda Hall and Nina Seigelstein, M.D., of Roswell Park Cancer Institute. The research was supported in part by grants from the National Institutes of Health.
-end-


University at Buffalo

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.